Abstract
A new molecular model for the permeability of drugs and other physiologically important compounds to cross the blood–brain barrier has been developed. Permeability (log PS) is dependant on desolvation, lipophilicity, molecular volume and dipole moment. Previous models for BBB permeability have not considered desolvation and dipole moment as critical factors. The model applies to passive diffusion processes, and some facilitated diffusion processes. Passive permeability models may not apply to active transport processes, where complex membrane protein binding processes (e.g. stereoselectivity) are involved. Model phosphatidylcholine lipid bilayer membranes have been used to evaluate how charged or polar neutral compounds can interact through their molecular dipoles with the cell membrane to induce electromechanical changes in the cell membrane which facilitate permeation. The free energy of solvation in n-octanol has been shown to be a good measure of membrane lipophilicity by calculating the solvation free energy of a model PC lipid membrane in a series of closely related alcohols. The passive diffusion model for alcohols correlates with the known modulation of membrane bilayers which showed a size-dependent “cut-off” point in potency. For most drugs and related molecules, the neutral species are the permeating species.
Similar content being viewed by others
Abbreviations
- BBB:
-
Blood–brain barrier
- CNS:
-
Central nervous system
- Log PS :
-
Log value of permeability surface area
- QSAR:
-
Quantitative structure–activity relationships
- PC:
-
Phosphatidylcholine
- DPPC:
-
Dipalmitotylphosphatidylcholine
- DPHYPC:
-
Diphytanoylphosphatidylcholine
- POPC:
-
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine
- DLPC:
-
Dilauroyl phosphatidylcholine
- DOPSE:
-
1,2-Dioleoyl phosphatidylserine
- QM:
-
Quantum mechanics
- PSA:
-
Molecular polar surface area
- ΔG water :
-
Water desolvation free energy
- ΔG octanol :
-
Solvation free energy in n-octanol, or lipophilicity
- V :
-
Molecular volume in n-octanol
- D :
-
Dipole moment in water
- SEE:
-
Standard error of the estimate (log PS)
- R 2 :
-
Regression correlation coefficient
References
Aagaard TH, Kristensen MN, Westh P (2006) Packing properties of 1-alkanols and alkanes in a phospholipid membrane. Biophys Chem 119:61
Abraham MH, Takacs K, Novak A, Mitchell RC (1997) On the partition of ampholytes: Application to blood-brain distribution. J Pharm Sci 86:310–315
Ingólfsson HI, Andersen OS (2011) Alcohol’s effects on lipid bilayer properties. Biophys J 101:847–855
Balaz S (2009) Modelling kinetics of subcellular disposition of chemicals. Chem Revs 109:1753–1899
Banks WA (2009) Characteristic of compounds that cross the blood-brain barrier. BMC Neurol 9(Suppl 1):S3
Barraud de Lagerie S, Comets E, Gautrand C, Fernandez C, Auchere D, Singlas E, Mentre F, Gimenez F (2004) Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice. Br J Pharmacol 141:1214–1222
Bezanilla F (2008) How membrane proteins sense voltage. Nat Rev Mol Cell Biol 9:323–332
Cafiso DS (1995) Influence of charges and dipoles on macromolecular adsorption and permeability, Ch. 9. In: Disalvo EA, Simon SA (eds) Permeability and stability of lipid bilayers. CRC Press, Boca Raton
Carpenter TS, Kirshner DA, Lau EY, Wong SE, Nilmeier JP, Lightstone FC (2014) A method to predict blood-brain barrier permeability of drug-like compounds using molecular dynamics simulations. Biophys J 107:630–641
Cattelotte J, Tournier N et al (2009) Changes in dipole potential at the mouse blood-brain barrier enhance the transport of technetium sestamibi. J Neurochem 108:767–775
Chew CF, Guy A, Biggin PC (2008) Distribution and dynamics of adamantanes in a lipid bilayer. Biophys J 95:5627–5636
Chiou JS, Kuo CC, Lin SH, Kamaya H, Ueda I (1991) Interfacial dehydration by alcohols: hydrogen bonding of alcohols to phospholipids. Alcohol 8:143–150
Ding Y et al (2004) Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration. Synapse 53:168–175
Fischer H, Gottschlich R, Seelig A (1998) Blood-brain barrier permeation: molecular parameters governing passive diffusion. J Membr Biol 165:201
Fong CW (2014) Statins in therapy: understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies. Eur J Med Chem 85:661–674
Gabathuler R (2010) Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurol Dis 37:48–57
Garg P, Verma J, Roy N (2008) In silico modelling of blood-brain barrier permeability predictions, in drug absorption studies. Biotechnol Pharm Asp AAPS 7:510
Goodwin JT, Clark DE (2005) In silico prediction of blood-brain barrier penetration. J Pharmacol Exp Ther 315:477–483
Gratton JA, Abraham MH, Bradbury MW, Chadha HS (1997) Molecular factors influencing drug transfer across the blood-brain barrier. J Pharm Pharmacol 49:1211–1216
Habgood MD, Knott GW, Dziegielewska KM, Saunders NR (1998) Permeability of the developing and mature blood-brain barriers to theophylline in rats. Clin Exp Pharmacol Physiol 25:361–368
Hawkins RA, O’Kane RL, Simpson IA, Viña JR (2006) Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 14:218S–226S
Heimburg T (2012) The capacitance and electromechanical coupling of lipid membranes close to transitions: the effect of electrostriction. Biophys J 103:918–929
Ho C, Williams BW, Kelly MB, Stubbs CD (1994) Chronic ethanol intoxication induces adaptive changes at the membrane protein/lipid interface. Biochimica et Biophysica Acta 1189:135–142
Hutt AJ (2006) Drug chirality and its pharmacological consequences. In: JohnSmith H, Williams H (eds) Introduction to the principles of drug design and action, 4th edn. CRC Press, Boca Raton
Jenkins AJ (2008) Pharmacokinetics of specific drugs. In: Karch SB (ed) Pharmacokinetics and pharmacodynamics of abused drugs. CRC Press, Boca Raton
Jouyban A, Soltani S (2012) Blood brain barrier permeation, in toxicity and drug testing. In: Acree W (ed) Intech. Instrument Society of America, Pittsburgh
Kaznessis YN (2005) A review of method for predicting blood-brain partitioning. Curr Med Chem 5:1
Keseru GM, Molnar L (2001) High-throughput prediction of blood-brain partitioning: a thermodynamic approach. J Chem Inf Comput Sci 41:120–128
Koerner MM, Palacio LA, Wright JW, Schweitzer KS, Ray BD, Petrache HI (2011) Electrodynamics of lipid membrane interactions in the presence of zwitterionic buffers. Biophys J 101:362–369
Liu X et al (2005) Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding. J Pharmacol Exp Therapeut 313:1254–1262
Liu X, Tu M, Kelly RS, Chen C, Smith BJ (2004a) Development of a computational approach to predict blood-brain barrier permeability. Drug Metab Dispos 32:132–139
Lombardo F, Blake JF, Curatolo WJ (1996) Computation of brain-blood partitioning of organic solutes via free energy calculations. J Med Chem 39:4750–4755
Lyon RC, McComb JA (1981) Schreurs J. Goldstein DB. A relationship between alcohol intoxication and the disordering of brain membranes by a series of short-chain alcohols. J Pharmacol Exp Ther 218:669–675
Mangas-Sanjuan V, González-Alvarez M, Gonzalez-Alvarez I, Bermejo M (2010) Drug penetration across the blood-brain barrier: an overview. Therapeut Deliv 1:1
Marenich AV, Cramer CJ, Truhlar DJ (2009) Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions. J Phys Chem B 113:6378–6396
Martin F, Zipse H (2005) Charge distribution in the water molecule—a comparison of methods. J Comp Chem 26:97–105
McAllister MS et al (2001) Mechanisms of glucose transport at the blood–brain barrier. Brain Res 409:20
McCaffrey G, Davis TP (2012) Physiology and pathophysiology of the blood-brain barrier: p-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery. J Invest Med 60:1
McCall AL, Millington WR, Wurtman RJ (1982) Blood-brain barrier transport of caffeine. Life Sci 31:2709–2715
McCreery MJ, Hunt WA (1978) Physico-chemical correlates of alcohol intoxication. Neuropharmacology 17:451–461
McKarns SC, Hansch C, Caldwell WS, Morgan WT, Moore SK, Doolittle DJ (1997) Correlation between hydrophobicity of short-chain aliphatic alcohols and their ability to alter plasma membrane integrity. Fundam Appl Toxicol 36:62–70
Mehdipour AR, Hamidi M (2009) Brain drug targeting: a computational approach to overcoming blood-brain barrier. Drug Discov Today 14:1030–1036
Nau R, Sorgel F, Eiffert H (2010) Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 23:858–883
Oldendorf WH, Szabo J (1976) Amino acid assignment to one of three blood-brain barrier amino acid carrier. Am J Physiol 230:94–98
Oldendorf WH, Hyman S, Braun L, Oldendorf SZ (1972) Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection, Science 178: 984–986. Log PS calculated from Oldendorf’s results for heroin, codeine and methadone based on morphine (-2.7, ref 15) as a base are -0.7, -1.15 and -0.9 respectively
Oldendorf WH, Braun L, Cornford E (1979) pH dependence of blood-brain permeability to lactate and nicotine. Stroke 10:577–581
Oldendorf WH, Stoller BE, Harris FL (1993) Blood-brain penetration abolished by N-methyl quaternization of nicotine. PNAS 90:307
Pajouhesh H, Lenz GR (2005) Medicinal chemical properties of successful central nervous system drugs. J Am Soc Exp Neuro Therapeut 2:541
Pardridge WM (2012) Drug transport across the blood-brain barrier. J Cerebral Blood Flow Metabol 32:1959–1972
Pardridge WM (2007) Blood-brain barrier delivery. Drug Discov Today 12:54–61
Peterson U, Mannock DA, Ruthven L, Pohl P, McElhaney RN, Pohl EE (2002) Origin of membrane dipole potential: contribution of the phospholipid fatty acid chains. Chem Phys Lipids 117:19
Rayne S, Forest K (2010) Accuracy of computational solvation free energies for neutral and ionic compounds: dependence on level of theory and solvent model. Nature Proceedings http://dx.doi.org/10.1038/npre.2010.4864.1
Smith QR (2000) Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr 130:1016S–1022S
Spector R (1987) Hypoxanthine transport through the blood-brain barrier. Neurochem Res 12:791–796
Spector R (1988) Myo-inositol transport across the blood-brain barrier. Neurochem Res 13:785–787
Stowasser C (2008) The dipole potential of lipid membranes—an overview. http://www.membranes.nbi.dk/thesis-pdf/2008_ProjectReport_C.Stowasser.pdf
Suenderhauf C, Hammann F, Huwyler J (2012) Computational prediction of blood-brain barrier permeability using decision tree induction. Molecules 17:10429–10445
Torres EG, Raul R, Gainetdinov MG, Caron G (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4:13
Trauble H (1971) The movement of free molecules across lipid membranes: a molecular theory. J Membr Biol 4:193–208
van Bree J et al (1991) Stereoselective transport of Baclofen across the blood-brain barrier in rats as determined by the unit impulse response method. Pharm Res 8:259–262
Vilar S, Chakrabarti M, Costanzi S (2010) Prediction of passive blood-brain partitioning: straightforward and effective classification models based on in silico derived physicochemical descriptors. J Mol Graph Model 28:899–903
Walter A, Gutknecht J (1986) Permeability of small nonelectrolytes through lipid bilayer membranes. J Membr Biol 90:207–217
Wu D, Kang Y, Bickel U, Pardridge WM (1997) Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab Dispos 25:768–771
Kubelka J Population Analysis, www.uwyo.edu/kubelka-chem/population_analysis.pdf
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fong, C.W. Permeability of the Blood–Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds. J Membrane Biol 248, 651–669 (2015). https://doi.org/10.1007/s00232-015-9778-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-015-9778-9